chronic hepatitis B.
Concurrence of Hepatitis B Surface Antigen and Antibody in Acute and Chronic Hepatitis B Cases
... Concurrence of Hepatitis B Surface Antigen and Antibody in Acute and Chronic Hepatitis B Cases ORIGINAL ARTICLE Concurrence of Hepatitis B Surface Antigen and Antibody in Acute and Chronic Hepatitis B[.] ...
5
Assessment of Risk Factors in Patients with Chronic Hepatitis B
... Chronic hepatitis B along with hepatic cirrhosis and hepatocellular carcinoma (HCC) causes a mortality of between ...with hepatitis B, of which 15-40% are prone to cirrhosis of the ...
17
Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA Mediated Control of Cholesterol Synthesis Programs
... ABSTRACT Chronic hepatitis B (CHB), chronic hepatitis C (CHC), and associated hepatocellular carcinoma (HCC) are charac- terized by cholesterol imbalance and dyslipidemia; however, the ...
13
Molecular characterization of hepatitis B virus X gene in chronic hepatitis B patients
... in chronic hepatitis patients infected with different genotypes, according to liver ...from chronic hepatitis B patient samples, analyzed by phylogeny and ...
7
Promoter methylation status and expression of PPAR-γ gene are associated with prognosis of acute-on-chronic hepatitis B liver failure
... of hepatitis B s antigen (HBsAg) in serum last for more than 6 months, and there was histological evidence of chronic hepatitis, according to the 2009 update of American Asso- ciation for the ...
9
Core Antigen Expression Is Associated with Hepatic Necroinflammation in e Antigen-Negative Chronic Hepatitis B Patients with Low DNA Loads
... Hepatitis B virus (HBV) is a circular, partially double- stranded DNA virus (10, ...to chronic hepatitis when it occurs in the neonatal period or early ...of chronic hepatitis ...
6
Characterization of the hepatitis B virus DNA detected in urine of chronic hepatitis B patients
... viral load (> 10 5 IU/mL) and 11 of 34 urine samples with low viral load (< 10 5 IU/mL) contained detectable HBV DNA in urine. By Fisher’s exact test, HBV DNA in urine is significantly associated with high serum ...
9
Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection
... ABSTRACT HBsAg and HBeAg have gained traction as biomarkers of control and clearance during chronic hepatitis B virus infection (CHB). Improved understanding of the clearance correlates of these ...
15
Hepatitis B Virus Core Related Antigens as Markers for Monitoring Chronic Hepatitis B Infection
... U/ml (5). In this assay, the specimens were pretreated so that HBeAg and HBcAg were released from the patients’ own anti-HBe and anti-HBc antibody-antigen complexes, respec- tively. Thus, both HBeAg and HBcAg can be ...
6
Elevated expression of serum soluble ST2 in clinical relapse after stopping long term Nucleos(t)ide analogue therapy for chronic hepatitis B
... Hepatitis B virus (HBV) infection causes acute and chronic hepatitis and remains a public health problem across the ...in chronic hepatitis B (CHB) patients [2, ...active ...
9
Original Article Clinical prognosis of chronic hepatitis B patients with concurrent HBeAg/Anti-HBe detection and possible mechanism
... of chronic hepatitis B (CHB), the loss of hepatitis B e antigen (HBeAg) and the production of antibody to HBeAg (Anti- HBe) (HBeAg seroconversion) is generally asso- ciated with ...
8
Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection
... Chronic hepatitis B viral infection is a global health prob- lem, especially in the Asian-Pacific ...with hepatitis B virus (HBV) worldwide and about 650,000 people die annually from ...
9
The serology of chronic hepatitis B infection revisited
... of chronic hepatitis B infection has been established through the use of commercial immunoassays to measure the structural antigens of the hepatitis B virus and their respective ...
11
Managing chronic hepatitis B: A qualitative study exploring the perspectives of people living with chronic hepatitis B in Australia
... Chronic hepatitis B is a complex condition mostly affecting people who may have understandings of the body that differ from those of the western medical ...of chronic hepatitis B ...
7
Chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants
... with Chronic-Hepatitis B (CHB)-associated Acute-on-Chronic Liver Failure ...in Chronic Hepatitis B patients with Acute/Chronic Liver ...in Chronic ...
8
Original Article Beta2-Glycoprotein I in Hepatitis B virus infection patients with hepatocellular carcinoma, chronic hepatitis B and acute hepatitis B
... on hepatitis B virus (HBV) infection patients with hepatocellular carcinoma (HCC), chronic hepatitis B (CHB) and acute hepatitis B ...
7
Longitudinal Study of Hepatitis Activity and Viral Replication before and after HBeAg Seroconversion in Chronic Hepatitis B Patients Infected with Genotypes B and C
... compare chronic hepatitis B (CHB) patients with genotypes B and C for the probability of HBeAg seroconversion, hepatitis activity, and viral replication before and after HBeAg serocon- ...
5
Safety and efficacy of entecavir for the treatment of chronic hepatitis B
... During the past decade, four new drugs (adefovir, entecavir, telbivudine, and tenofovir) have been approved for the treatment of chronic hepatitis B virus (HBV), joining lamivudine as options for ...
10
T bet expression in CD8+ T cells associated with chronic hepatitis B virus infection
... showed expression of T-bet was in accordance with HBV specific CD8+ T cell response. Similar results con- cerning T-bet expression were observed in HIV infected patients [11]. Our data suggest that T-bet might regulate ...
10
HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg positive chronic hepatitis B patients
... The twenty HBeAg-positive CHB patients were classi- fied into SC (n = 9) or non-SC (n = 11) groups, depend- ing on whether they had undergone SC by week 72 of TDF treatment. Subjects with CHB fulfilled the defini- tions ...
9